EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial

Radwa M Shalaby iD, Soheir M El-Kosery iD, Mahmoud M Soliman iD, Doaa A Osman iD

Physiotherapy Research International · 2024

DOI: 10.1002/pri.2129 ↗

At a glance

Randomisierte kontrollierte Studie in Physiotherapy Research International, 2024. Written by Radwa M Shalaby and 3 co-authors. Institution: Faculty of Physical Therapy, Cairo University, Giza, Egypt. Major MEDLINE topics: Candidiasis, Vulvovaginal. Cited 3 times so far (Crossref); 32 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Vulvovaginal Candidiasis (VVC) is a prevalent genital infection in women of reproductive age and requires effective non‐drug therapies. Therefore, this study aimed to investigate the effect of blue light emitting diode (LED) therapy as an alternative treatment for recurrent VVC due to its proven antimicrobial properties. The safety and non‐invasiveness of LED therapy make it a promising option for sensitive tissue applications. Materials and Methods This randomized controlled trial recruited 60 women with culture‐confirmed VVC. Participants were randomly allocated to two groups. Group A (control group) received standard antifungal treatment with Gynoconazol 0.8% vaginal cream for three consecutive nights (n = 30). Group B (study group) received the same antifungal treatment plus two 60‐min sessions of blue LED therapy directed at the vagina and vulva, with the sessions separated by two days (n = 30). Candida count (via CHROMagar™ Candida) and vaginal pH (via AD110‐AD111 m) were assessed at baseline and one week after initiating treatment.

Results

Post‐treatment, group (B) demonstrated a significantly greater reduction in Candida count compared to group (A) (mean difference (MD) 8.267; 95% Confidence Interval (CI) 6.723–9.811; p = 0.0001). However, there was no statistically significant difference in vaginal pH between the groups (MD −0.03; 95% CI −0.244–0.178; p = 0.749).

Conclusion

Blue LED therapy effectively reduces Candida count in women with recurrent VVC without adversely affecting the vaginal pH, highlighting its safety and efficacy as a treatment modality.

Subjects

MeSH terms (MEDLINE)

Candidiasis, VulvovaginalHumansFemaleAdultPhototherapyAntifungal AgentsRecurrenceYoung AdultSingle-Blind MethodTreatment OutcomeBlue Light

Author keywords

Candida countWomen's healthblue light emitting diode therapyintegrative medicinerecurrent vulvovaginal candidiasisvaginal pH

Substances

Antifungal Agents

Authors and institutions

  • Faculty of Physical Therapy, Cairo University, Giza, Egypt.
  • Department of Physical Therapy for Women's Health, Cairo University, Giza, Egypt.
  • Department of Gynecology and Obstetrics, Faculty of Medicine, Cairo University, Giza, Egypt.

ORCID profiles: Radwa M Shalaby, Soheir M El-Kosery, Mahmoud M Soliman, Doaa A Osman

Cite

APA

Shalaby, R. M., El-Kosery, S. M., Soliman, M. M., & Osman, D. A. (2024). Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial. Physiotherapy Research International. https://doi.org/10.1002/pri.2129

Vancouver

Shalaby RM, El-Kosery SM, Soliman MM, Osman DA. Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial. Physiotherapy Research International. 2024. doi:10.1002/pri.2129

BibTeX
@article{Shalaby2024,
  author = {Shalaby, Radwa M and El-Kosery, Soheir M and Soliman, Mahmoud M and Osman, Doaa A},
  title = {Effect of blue light emitting diode therapy on recurrent vulvovaginal candidiasis: A randomized assessor‐blinded controlled trial},
  journal = {Physiotherapy Research International},
  year = {2024},
  doi = {10.1002/pri.2129}
}
Start for free →